FDA Guidance on Cannabis Research: A Glimpse of What’s To Come for CBD Products?
On Tuesday, July 21, the Food and Drug Administration (“FDA”) released draft guidance for clinical research related to the development and manufacturing of cannabis-based drugs, which gained particular interest following the legalization of hemp in December 2018. Although the guidance does not cover other FDA-regulated products, such as hemp-derived CBD (“Hemp CBD”)-infused foods and dietary […]
FDA Guidance on Cannabis Research: A Glimpse of What’s To Come for CBD Products? Read More »
